-
Schoolgirl Yu, 13, fastest again in bid for third Asian Games gold
-
Mongolian herders enlist new tech against harsher, drier climate
-
Oil prices fall after Trump hails 'good' talks with Iran
-
Tata turmoil shines light on India succession woes
-
AI political ads warp reality ahead of US midterms
-
World Cup 'not enough' as Spain begin next chapter
-
Kenneth Branagh embraces action hero role -- to get in shape
-
Meta acts against 3.7 mn scammers' accounts with Singapore police help
-
'New one' Klopp promises fresh approach as Germany reign begins
-
Australia PM says draft social media rules about taking back control
-
Milne returns to New Zealand squad for India T20 series
-
Voting opens in Alaska's annual Fat Bear Week
-
US-led Americas coalition backs sanctions against crime groups
-
MLS coach axed for telling female ref 'It's a man's game'
-
'Star Wars' fans and art lovers line up for new Lucas museum
-
US refuses to give Sudan's de facto leader visa for UN
-
Trump renames AI 'super intelligence' as leaders jostle over dangers
-
Man City hold Bayern to start Women's Champions League, Arsenal win late
-
Oil prices retreat as markets welcome US-Iran talks
-
Trump threatens Iran with 'hell' but reveals fresh talks
-
US refusing to give Sudan's de facto leader visa for UN: diplomatic sources, UN
-
Trump signs security deal with Greenland, Denmark at UN
-
Macron urges world to choose UN over 'law of the jungle'
-
Trump threatens Iran with 'hell' but unveils fresh talks
-
All-rounder Jacks stars as England beat Sri Lanka in 1st ODI
-
Chile's Atacama Desert blossoms with life after El Nino rains
-
Man City peg back Bayern to start Women's Champions League
-
Sri Lanka hands 220-year jail terms to 15 convicted of Easter bombings
-
Trump beats 'America first' drum at UN as allies tread carefully
-
Typhoon Dujuan leaves 7 dead in Japan from landslides, flooding: media
-
Snedeker backs Spaun for Ryder Cup after Presidents snub
-
Ganna and Borghini lead Italy to mixed relay gold at cycling worlds
-
French prosecutors probe secret filming of women with smart glasses
-
Drug cocktail killed former child star Hayden Panettiere: coroner
-
Trump renames AI "super intelligence," rejects international oversight
-
Moldova declares energy, water emergency
-
Trump rejects international regulation of AI
-
French Holocaust denier jailed for eight months
-
How is the EU approaching record fuel prices?
-
Oil prices slide, AI stock buzz fades
-
Sri Lanka's Colombage strikes on debut as England dismissed for 265 in first ODI
-
Trump threatens to 'annihilate' Iran in bombastic UN speech
-
Hurricane Polo strengthens to top category 5 off Mexico
-
Prada's skirts take centre stage as Milan Fashion Week begins
-
11 hurt as teen opens fire outside school in western Turkey
-
Quoin Pharmaceuticals Announces FDA Fast Track Designation for QRX003 for the Treatment of Peeling Skin Syndrome
-
UN chief says 'Big Oil' treats atmosphere as open sewer
-
Brazil's Flavio Bolsonaro turns scandal into poll gains
-
Tunisia says 2026 summer hottest on record
-
Republican senator seeks probe of Trump Jr Russian-funded wedding
Conflicting US rulings leave fate of abortion pill in doubt
Conflicting rulings by two federal judges have left the future of abortion pills in the United States deeply uncertain, likely placing the divisive issue squarely in the lap of the Supreme Court.
A ruling Friday by federal judge Matthew Kacsmaryk in Texas banned the widely used drug mifepristone (RU 486) nationwide, boosting conservatives' efforts to further restrict abortion rights after the Supreme Court last year allowed states to prohibit them.
The unprecedented rejection of a drug approved in 2000 by the US Food and Drug Administration (FDA) -- and found safe by scientific consensus -- sparked outrage on the political left.
Kacsmaryk, in his ruling, adopted language used by abortion opponents, referring to abortion providers as "abortionists" and saying the drug was used to "kill the unborn human."
His ruling brought an immediate vow from the Biden administration and the drug's maker to appeal the matter in federal court.
Attorney General Merrick Garland said the Justice Department would ask the appeals court to stay the ban by Kacsmaryk, an ultraconservative Donald Trump appointee, until the case is finally resolved.
If the Texas ruling holds, it would complicate matters not just in the states now banning or sharply limiting abortions, but also in those where the procedure remains legal.
- Widely used -
Mifepristone has been used as part of a two-drug regimen by 5.6 million women since 2000.
But adding to the uncertainty and increasing the odds the matter ends up before the Supreme Court was a contradictory ruling from a Washington state judge that came just hours after Kacsmaryk's.
District Judge Thomas Rice, a Barack Obama appointee, ruled in a separate case -- brought by several states where abortion is legal -- that mifepristone is "safe and legal" and that the FDA must preserve access to it in more than a dozen states.
For now the drug remains legal, Alexis McGill Johnson, the head of Planned Parenthood, one of the largest pro-abortion groups in the country, said Friday.
Several abortion clinics also said Friday that they would continue using mifepristone until ordered not to by the FDA, US media reported.
Kacsmaryk paused the effect of his ruling for a week, allowing time for the administration and drugmaker Danco Laboratories to file before the US Fifth Circuit Court of Appeals in Louisiana, which hears cases from Texas.
The Justice Department is still reviewing Rice's ruling, Garland said in a statement.
- 'Remains safe' -
Given the sharply conflicting court rulings, the Justice Department might opt to take the case directly to the Supreme Court and not wait for the Fifth Circuit to act.
The high court could decide to take up the case on an emergency basis, which would require making room in an already crowded agenda at the end of the current term.
In that case, the court -- with six conservative justices outnumbering the three liberals -- could hear the case within days, or weeks, but sometime before the current session ends on June 30.
Chief Justice John Roberts, a conservative, is deeply protective of the image of the institution, and he might be expected to vote with the three liberals in favor of mifepristone. The additional vote of one other conservative could provide a majority for the drug.
The court's ruling last June to overturn the longstanding Roe v. Wade decision protecting abortion rights shifted considerable attention to medication abortions.
Most of them involve mifepristone in a two-drug regimen. A patient first takes a mifepristone pill to end the pregnancy, then a day later takes the drug misoprostol to induce contractions that expel the embryo or fetus.
Misoprostol can be used on its own to cause abortions, but the two-step procedure is considered more effective and can be more painful.
More than half of abortions in the US are done with medication.
Kacsmaryk, in his ruling, said the two-drug regimen had resulted in "thousands of adverse events suffered by women and girls," including intense bleeding and psychological trauma.
But the FDA, researchers and the drugmaker say decades of experience have proven the medication to be safe and effective.
Michigan Governor Gretchen Whitmer, a Democrat, tweeted:
"Despite this ruling, I want to be clear: abortion, including medication abortion, remains safe and legal in the state of Michigan."
Women's March, which has been organizing organizing major women's rights demonstrations in recent years, called for a nationwide rally defending abortion rights for April 15.
J.V.Jacinto--PC